Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Royal Hobart Hospital |
---|---|
Information provided by: | Royal Hobart Hospital |
ClinicalTrials.gov Identifier: | NCT00500669 |
To investigate whether Betadine can reduce infection rates and recurrence rates following varicose veins sugery in a randomised double blind placebo controlled study.
Condition | Intervention | Phase |
---|---|---|
Varicose Veins Wound Infection Recurrence |
Drug: Betadine |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Efficacy Study |
Official Title: | A Randomised, Blinded Study to Assess the Effect of Betadine in the Groin Wound of Patients Undergoing Primary Varicose Vein Surgery |
Estimated Enrollment: | 60 |
Study Start Date: | June 2004 |
Estimated Study Completion Date: | July 2008 |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Stuart Walker, MBBS | 03 62227064 | stuart.walker@dhhs.tas.gov.au |
Australia, Tasmania | |
Royal Hobart Hospital | Recruiting |
Hobart, Tasmania, Australia, 7001 | |
Contact: Stuart Walker stuart.walker@dhhs.tas.gov.au |
Principal Investigator: | Stuart Walker, MBBS | Royal Hobart Hospital |
Study ID Numbers: | H0011 |
Study First Received: | July 12, 2007 |
Last Updated: | July 12, 2007 |
ClinicalTrials.gov Identifier: | NCT00500669 |
Health Authority: | Australia: Human Research Ethics Committee |
Varicose veins wound infection recurrence |
Varicose Veins Povidone Wounds and Injuries Vascular Diseases Iodine |
Disorders of Environmental Origin Povidone-Iodine Recurrence Wound Infection |
Anti-Infective Agents Anti-Infective Agents, Local Disease Attributes Pathologic Processes |
Therapeutic Uses Cardiovascular Diseases Infection Pharmacologic Actions |